Gluconorm (repaglinide) - New Contraindication for Concomitant Use with Clopidogrel
Issued July 31, 2015
Issue
Co-administration of repaglinide and clopidogrel (a known CYP2C8 inhibitor), may lead to a significant decrease in blood glucose levels due to a drug-drug interaction.
Hazard description
Product safety
Get notified of similar recallsEnter your email to receive alerts when new recalls are issued by the same agency.
Subscribed. You'll get an email when new recalls are issued.
RecallTracker